A large biotech fund that's an insider at Cogent Biosciences recently sold millions of shares amid the company's best annual ...

Centessa Pharmaceuticals develops therapies for rare and serious diseases, advancing a pipeline of clinical-stage and emerging candidates.

Discover India's strategic budget focused on long-term growth through innovation in agriculture, healthcare, and ...

DOVER, DE, UNITED STATES, January 21, 2026 /EINPresswire.com/ -- The global pharmaceutical supply chain is currently ...

Union Budget 2026 shows that technology, science and innovation are no longer side topics but core to India’s growth plan. While presenting the Budget, Finance Minister Nirmala Sitharaman underlined ...

From life-saving vaccines to advanced cancer therapies, biopharmaceuticals are quietly transforming modern medicine. Made ...

Finance Minister Nirmala Sitharaman set the tone early in her Budget 2026 speech, describing it as the first Budget prepared ...

Finance Minister Nirmala Sitharaman announces Biopharma Shakti, a ₹10,000 crore plan to boost biologics, biosimilars, clinical trials and regulatory capacity in India.

At a recent global symposium, specialists unveiled that Northeast India's diverse ecosystem is on the brink of transforming ...

The finance minister Nirmala Sitharaman introduced a new scheme "Biopharma Shakti" with an outlay of INR 10,000 Cr for the upcoming five years.

A Rs 10,000-crore push aims to build India’s biopharma and advanced manufacturing capabilities as disease patterns and technology priorities shift.

The robots are coming for health care, just like they are for virtually everything else. But in this very narrow instance, at least, that may actually be a good thing. In the spirit of a week ...